SPOTLIGHT -
How Glaucoma Care Changed During COVID-19 Pandemic
A literature review finds that glaucoma care changed for the better during the COVID-19 pandemic.
Reproxalap Nears FDA Submission
The drug is a potential new therapy for dry eye disease with a novel mechanism of action.
Driving Down Insulin Prices Takes a Group Effort
As Congress considers legislation that would cap out-of-pocket costs for insulin, Walmart and Civica Rx are taking steps that could make less expensive versions of the diabetes medication more available.
Enhancements Needed in Value-based Pharmacy Contracts, Study Shows
Collaboration among stakeholders is needed to increase transparency of pharmacy payment programs and to better align the design of these models with good patient care.
Collaboration Is Key to Improve Performance-Based Pharmacy Contracts
Collaboration among stakeholders can increase transparency of pharmacy payment programs and better align the design of these models with enhanced patient care.